is retatrutide glp 1 or glp 3 vs Semaglutide and Tirzepatide: GLP-3 Facts explained Retatrutide peptide for weight loss

Tirzepatida (Mounjaro, Zepbound) Aplicao: 1x por semana Dose mxima: 15 mg um duplo agonista: age no receptor de GLP-1 e no de GIP Resultados: perda de peso de at 21%, maior do que a semaglutida Ambos j foram aprovados por agncias reguladoras para tratar diabetes e obesidade, e esto sendo estudados para muitas outras doenas

Getting started was easy and some of the concerns I had were alleviated through the fact based consultation I had

"FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs." Press release, February 6, 2026

Acosta A, Camilleri M, Burton D, ONeill J, Eckert D, Carlson P et al

With regular use, you'll see results in as little as 12 weeks

Conclusion Mazdutide and tirzepatide represent significant advancements in obesity and type 2 diabetes management, leveraging GLP-1-based mechanisms to achieve weight loss and glycaemic control